Back to Results
First PageMeta Content



Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr
Add to Reading List

Document Date: 2015-11-04 13:26:51


Open Document

File Size: 526,29 KB

Share Result on Facebook
UPDATE